Cargando…

Transpulmonary thermodilution using femoral indicator injection: a prospective trial in patients with a femoral and a jugular central venous catheter

INTRODUCTION: Advanced hemodynamic monitoring using transpulmonary thermodilution (TPTD) is established for measurement of cardiac index (CI), global end-diastolic volume index (GEDVI) and extra-vascular lung water index (EVLWI). TPTD requires indicator injection via a central venous catheter (usual...

Descripción completa

Detalles Bibliográficos
Autores principales: Saugel, Bernd, Umgelter, Andreas, Schuster, Tibor, Phillip, Veit, Schmid, Roland M, Huber, Wolfgang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911732/
https://www.ncbi.nlm.nih.gov/pubmed/20500825
http://dx.doi.org/10.1186/cc9030
_version_ 1782184507412054016
author Saugel, Bernd
Umgelter, Andreas
Schuster, Tibor
Phillip, Veit
Schmid, Roland M
Huber, Wolfgang
author_facet Saugel, Bernd
Umgelter, Andreas
Schuster, Tibor
Phillip, Veit
Schmid, Roland M
Huber, Wolfgang
author_sort Saugel, Bernd
collection PubMed
description INTRODUCTION: Advanced hemodynamic monitoring using transpulmonary thermodilution (TPTD) is established for measurement of cardiac index (CI), global end-diastolic volume index (GEDVI) and extra-vascular lung water index (EVLWI). TPTD requires indicator injection via a central venous catheter (usually placed via the jugular or subclavian vein). However, superior vena cava access is often not feasible due to the clinical situation. This study investigates the conformity of TPTD using femoral access. METHODS: This prospective study involved an 18-month trial at a medical intensive care unit at a university hospital. Twenty-four patients with both a superior and an inferior vena cava catheter at the same time were enrolled in the study. RESULTS: TPTD-variables were calculated from TPTD curves after injection of the indicator bolus via jugular access (TPTDjug) and femoral access (TPTDfem). GEDVIfem and GEDVIjug were significantly correlated (r(m )= 0.88; P < 0.001), but significantly different (1,034 ± 275 vs. 793 ± 180 mL/m(2); P < 0.001). Bland-Altman analysis demonstrated a bias of +241 mL/m(2 )(limits of agreement: -9 and +491 mL/m(2)). GEDVIfem, CIfem and ideal body weight were independently associated with the bias (GEDVIfem-GEDVIjug). A correction formula of GEDVIjug after femoral TPTD, was calculated. EVLWIfem and EVLWIjug were significantly correlated (r(m )= 0.93; P < 0.001). Bland-Altman analysis revealed a bias of +0.83 mL/kg (limits of agreement: -2.61 and +4.28 mL/kg). Furthermore, CIfem and CIjug were significantly correlated (r(m )= 0.95; P < 0.001). Bland-Altman analysis demonstrated a bias of +0.29 L/min/m(2 )(limits of agreement -0.40 and +0.97 L/min/m(2); percentage-error 16%). CONCLUSIONS: TPTD after femoral injection of the thermo-bolus provides precise data on GEDVI with a high correlation, but a self-evident significant bias related to the augmented TPTD-volume. After correction of GEDVIfem using a correction formula, GEDVIfem shows high predictive capabilities for GEDVIjug. Regarding CI and EVLWI, accurate TPTD-data is obtained using femoral access.
format Text
id pubmed-2911732
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29117322010-07-29 Transpulmonary thermodilution using femoral indicator injection: a prospective trial in patients with a femoral and a jugular central venous catheter Saugel, Bernd Umgelter, Andreas Schuster, Tibor Phillip, Veit Schmid, Roland M Huber, Wolfgang Crit Care Research INTRODUCTION: Advanced hemodynamic monitoring using transpulmonary thermodilution (TPTD) is established for measurement of cardiac index (CI), global end-diastolic volume index (GEDVI) and extra-vascular lung water index (EVLWI). TPTD requires indicator injection via a central venous catheter (usually placed via the jugular or subclavian vein). However, superior vena cava access is often not feasible due to the clinical situation. This study investigates the conformity of TPTD using femoral access. METHODS: This prospective study involved an 18-month trial at a medical intensive care unit at a university hospital. Twenty-four patients with both a superior and an inferior vena cava catheter at the same time were enrolled in the study. RESULTS: TPTD-variables were calculated from TPTD curves after injection of the indicator bolus via jugular access (TPTDjug) and femoral access (TPTDfem). GEDVIfem and GEDVIjug were significantly correlated (r(m )= 0.88; P < 0.001), but significantly different (1,034 ± 275 vs. 793 ± 180 mL/m(2); P < 0.001). Bland-Altman analysis demonstrated a bias of +241 mL/m(2 )(limits of agreement: -9 and +491 mL/m(2)). GEDVIfem, CIfem and ideal body weight were independently associated with the bias (GEDVIfem-GEDVIjug). A correction formula of GEDVIjug after femoral TPTD, was calculated. EVLWIfem and EVLWIjug were significantly correlated (r(m )= 0.93; P < 0.001). Bland-Altman analysis revealed a bias of +0.83 mL/kg (limits of agreement: -2.61 and +4.28 mL/kg). Furthermore, CIfem and CIjug were significantly correlated (r(m )= 0.95; P < 0.001). Bland-Altman analysis demonstrated a bias of +0.29 L/min/m(2 )(limits of agreement -0.40 and +0.97 L/min/m(2); percentage-error 16%). CONCLUSIONS: TPTD after femoral injection of the thermo-bolus provides precise data on GEDVI with a high correlation, but a self-evident significant bias related to the augmented TPTD-volume. After correction of GEDVIfem using a correction formula, GEDVIfem shows high predictive capabilities for GEDVIjug. Regarding CI and EVLWI, accurate TPTD-data is obtained using femoral access. BioMed Central 2010 2010-05-25 /pmc/articles/PMC2911732/ /pubmed/20500825 http://dx.doi.org/10.1186/cc9030 Text en Copyright ©2010 Saugel et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Saugel, Bernd
Umgelter, Andreas
Schuster, Tibor
Phillip, Veit
Schmid, Roland M
Huber, Wolfgang
Transpulmonary thermodilution using femoral indicator injection: a prospective trial in patients with a femoral and a jugular central venous catheter
title Transpulmonary thermodilution using femoral indicator injection: a prospective trial in patients with a femoral and a jugular central venous catheter
title_full Transpulmonary thermodilution using femoral indicator injection: a prospective trial in patients with a femoral and a jugular central venous catheter
title_fullStr Transpulmonary thermodilution using femoral indicator injection: a prospective trial in patients with a femoral and a jugular central venous catheter
title_full_unstemmed Transpulmonary thermodilution using femoral indicator injection: a prospective trial in patients with a femoral and a jugular central venous catheter
title_short Transpulmonary thermodilution using femoral indicator injection: a prospective trial in patients with a femoral and a jugular central venous catheter
title_sort transpulmonary thermodilution using femoral indicator injection: a prospective trial in patients with a femoral and a jugular central venous catheter
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911732/
https://www.ncbi.nlm.nih.gov/pubmed/20500825
http://dx.doi.org/10.1186/cc9030
work_keys_str_mv AT saugelbernd transpulmonarythermodilutionusingfemoralindicatorinjectionaprospectivetrialinpatientswithafemoralandajugularcentralvenouscatheter
AT umgelterandreas transpulmonarythermodilutionusingfemoralindicatorinjectionaprospectivetrialinpatientswithafemoralandajugularcentralvenouscatheter
AT schustertibor transpulmonarythermodilutionusingfemoralindicatorinjectionaprospectivetrialinpatientswithafemoralandajugularcentralvenouscatheter
AT phillipveit transpulmonarythermodilutionusingfemoralindicatorinjectionaprospectivetrialinpatientswithafemoralandajugularcentralvenouscatheter
AT schmidrolandm transpulmonarythermodilutionusingfemoralindicatorinjectionaprospectivetrialinpatientswithafemoralandajugularcentralvenouscatheter
AT huberwolfgang transpulmonarythermodilutionusingfemoralindicatorinjectionaprospectivetrialinpatientswithafemoralandajugularcentralvenouscatheter